Montes Archimedes Acquisition Corp. focuses to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in Menlo Park, California.
IPO Year: 2020
Exchange: NASDAQ
Website: montesarchimedesacquisitioncorp.com
| Date | Price Target | Rating | Analyst |
|---|
Fastest customizable press release news feed in the world
Roivant will begin trading on Nasdaq under the ticker "ROIV" later todayR&D Day presentations from September 28th highlighting Roivant's pipeline and discovery platform available on Roivant's investor page BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Roivant Sciences, a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it has closed its business combination with Montes Archimedes Acquisition Corp. (NASDAQ:MAAC), a special purpose acquisition company, as well as a concurrent PIPE financing. Outstanding shares and warrants of MAAC have been exchanged for newly issued Roivant shares and w
NEW YORK and BASEL, Switzerland, June 9, 2021 /PRNewswire/ -- Roivant Sciences today announced that Datavant, the leader in helping healthcare organizations securely connect their data, and Ciox Health, the leader in clinical data exchange, have signed a definitive merger agreement. The combined entity, to be named Datavant, will be the nation's largest health data ecosystem, enabling patients, providers, payers, health data analytics companies, patient-facing applications, government agencies, and life science companies to securely exchange their patient-level data. The combined company will have an enterprise value of $7 billion. The merger is subject to typical regulatory approvals and is
NEW YORK, MENLO PARK, Calif., LONDON, and BASEL, Switzerland, May 3, 2021 /PRNewswire/ -- Roivant Sciences, a biopharmaceutical and healthcare technology company, and Montes Archimedes Acquisition Corp. (NASDAQ:MAAC), a special purpose acquisition company sponsored by Patient Square Capital, today announced that they have entered into a definitive business combination agreement. Upon closing of the transaction, outstanding shares and warrants of MAAC will be exchanged for newly issued shares and warrants of Roivant Sciences, which is expected to be listed on Nasdaq under the new ticker symbol "ROIV." The transaction is expected to deliver up to $611 million of gross proceeds to fund discover
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Montes Archimedes Acquisition Corp (0001819263) (Issuer)
4 - Montes Archimedes Acquisition Corp (0001819263) (Issuer)
4 - Montes Archimedes Acquisition Corp (0001819263) (Issuer)
4 - Montes Archimedes Acquisition Corp (0001819263) (Issuer)
4 - Montes Archimedes Acquisition Corp (0001819263) (Issuer)
15-12B - Montes Archimedes Acquisition Corp (0001819263) (Filer)
25-NSE - Montes Archimedes Acquisition Corp (0001819263) (Subject)
8-K - Montes Archimedes Acquisition Corp (0001819263) (Filer)
425 - Montes Archimedes Acquisition Corp (0001819263) (Subject)
8-K - Montes Archimedes Acquisition Corp (0001819263) (Filer)
10-Q - Montes Archimedes Acquisition Corp (0001819263) (Filer)
DEFM14A - Montes Archimedes Acquisition Corp (0001819263) (Filer)
425 - Montes Archimedes Acquisition Corp (0001819263) (Filed by)
8-K - Montes Archimedes Acquisition Corp (0001819263) (Filer)
8-K - Montes Archimedes Acquisition Corp (0001819263) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G/A - Montes Archimedes Acquisition Corp (0001819263) (Subject)
SC 13G - Montes Archimedes Acquisition Corp (0001819263) (Subject)
SC 13G - Montes Archimedes Acquisition Corp (0001819263) (Subject)